Why we should allow performance enhancing drugs in sport
- 1Uehiro Chair of Practical Ethics, University of Oxford, Oxford, UK
- 2Murdoch Childrens Research Institute, Melbourne, Victoria, Australia
- Correspondence to: Professor Savulescu Flat 2, 3 Bradmore Road, Oxford OX2 6QW, UK;
The legalisation of drugs in sport may be fairer and safer
In 490 BC, the Persian Army landed on the plain of Marathon, 25 miles from Athens. The Athenians sent a messenger named Feidipides to Sparta to ask for help. He ran the 150 miles in two days. The Spartans were late. The Athenians attacked and, although outnumbered five to one, were victorious. Feidipides was sent to run back to Athens to report victory. On arrival, he screamed “We won” and dropped dead from exhaustion.
The marathon was run in the first modern Olympics in 1896, and in many ways the athletic ideal of modern athletes is inspired by the myth of the marathon. Their ideal is superhuman performance, at any cost.
DRUGS IN SPORT
The use of performance enhancing drugs in the modern Olympics is on record as early as the games of the third Olympiad, when Thomas Hicks won the marathon after receiving an injection of strychnine in the middle of the race.1 The first official ban on “stimulating substances” by a sporting organisation was introduced by the International Amateur Athletic Federation in 1928.2
Using drugs to cheat in sport is not new, but it is becoming more effective. In 1976, the East German swimming team won 11 out of 13 Olympic events, and later sued the government for giving them anabolic steroids.3 Yet despite the health risks, and despite the regulating bodies’ attempts to eliminate drugs from sport, the use of illegal substances is widely known to be rife. It hardly raises an eyebrow now when some famous athlete fails a dope test.
In 1992, Vicky Rabinowicz interviewed small groups of athletes. She found that Olympic athletes, in general, believed that most successful athletes were using banned substances.4
Much of the writing on the use of drugs in sport is focused on this kind of anecdotal evidence. There is very little rigorous, objective evidence because the athletes are doing something that is taboo, illegal, and sometimes highly dangerous. The anecdotal picture tells us that our attempts to eliminate drugs from sport have failed. In the absence of good evidence, we need an analytical argument to determine what we should do.
CONDEMNED TO CHEATING?
We are far from the days of amateur sporting competition. Elite athletes can earn tens of millions of dollars every year in prize money alone, and millions more in sponsorships and endorsements. The lure of success is great. But the penalties for cheating are small. A six month or one year ban from competition is a small penalty to pay for further years of multimillion dollar success.
Drugs are much more effective today than they were in the days of strychnine and sheep’s testicles. Studies involving the anabolic steroid androgen showed that, even in doses much lower than those used by athletes, muscular strength could be improved by 5–20%.5 Most athletes are also relatively unlikely to ever undergo testing. The International Amateur Athletic Federation estimates that only 10–15% of participating athletes are tested in each major competition.6
The enormous rewards for the winner, the effectiveness of the drugs, and the low rate of testing all combine to create a cheating “game” that is irresistible to athletes. Kjetil Haugen7 investigated the suggestion that athletes face a kind of prisoner’s dilemma regarding drugs. His game theoretic model shows that, unless the likelihood of athletes being caught doping was raised to unrealistically high levels, or the payoffs for winning were reduced to unrealistically low levels, athletes could all be predicted to cheat. The current situation for athletes ensures that this is likely, even though they are worse off as a whole if everyone takes drugs, than if nobody takes drugs.
Drugs such as erythropoietin (EPO) and growth hormone are natural chemicals in the body. As technology advances, drugs have become harder to detect because they mimic natural processes. In a few years, there will be many undetectable drugs. Haugen’s analysis predicts the obvious: that when the risk of being caught is zero, athletes will all choose to cheat.
The recent Olympic games in Athens were the first to follow the introduction of a global anti-doping code. From the lead up to the games to the end of competition, 3000 drug tests were carried out: 2600 urine tests and 400 blood tests for the endurance enhancing drug EPO.8 From these, 23 athletes were found to have taken a banned substance—the most ever in an Olympic games.9 Ten of the men’s weightlifting competitors were excluded.
The goal of “cleaning” up the sport is unattainable. Further down the track the spectre of genetic enhancement looms dark and large.
THE SPIRIT OF SPORT
So is cheating here to stay? Drugs are against the rules. But we define the rules of sport. If we made drugs legal and freely available, there would be no cheating.
The World Anti-Doping Agency code declares a drug illegal if it is performance enhancing, if it is a health risk, or if it violates the “spirit of sport”.10 They define this spirit as follows.11 The spirit of sport is the celebration of the human spirit, body, and mind, and is characterised by the following values:
ethics, fair play and honesty
excellence in performance
character and education
fun and joy
dedication and commitment
respect for rules and laws
respect for self and other participants
community and solidarity
Would legal and freely available drugs violate this “spirit”? Would such a permissive rule be good for sport?
Human sport is different from sports involving other animals, such as horse or dog racing. The goal of a horse race is to find the fastest horse. Horses are lined up and flogged. The winner is the one with the best combination of biology, training, and rider. Basically, this is a test of biological potential. This was the old naturalistic Athenian vision of sport: find the strongest, fastest, or most skilled man.
Training aims to bring out this potential. Drugs that improve our natural potential are against the spirit of this model of sport. But this is not the only view of sport. Humans are not horses or dogs. We make choices and exercise our own judgment. We choose what kind of training to use and how to run our race. We can display courage, determination, and wisdom. We are not flogged by a jockey on our back but drive ourselves. It is this judgment that competitors exercise when they choose diet, training, and whether to take drugs. We can choose what kind of competitor to be, not just through training, but through biological manipulation. Human sport is different from animal sport because it is creative. Far from being against the spirit of sport, biological manipulation embodies the human spirit—the capacity to improve ourselves on the basis of reason and judgment. When we exercise our reason, we do what only humans do.
The result will be that the winner is not the person who was born with the best genetic potential to be strongest. Sport would be less of a genetic lottery. The winner will be the person with a combination of the genetic potential, training, psychology, and judgment. Olympic performance would be the result of human creativity and choice, not a very expensive horse race.
Classical musicians commonly use β blockers to control their stage fright. These drugs lower heart rate and blood pressure, reducing the physical effects of stress, and it has been shown that the quality of a musical performance is improved if the musician takes these drugs.12 Although elite classical music is arguably as competitive as elite sport, and the rewards are similar, there is no stigma attached to the use of these drugs. We do not think less of the violinist or pianist who uses them. If the audience judges the performance to be improved with drugs, then the drugs are enabling the musician to express him or herself more effectively. The competition between elite musicians has rules—you cannot mime the violin to a backing CD. But there is no rule against the use of chemical enhancements.
Is classical music a good metaphor for elite sport? Sachin Tendulkar is known as the “Maestro from Mumbai”. The Associated Press called Maria Sharapova’s 2004 Wimbledon final a “virtuoso performance”.13 Jim Murray14 wrote the following about Michael Jordan in 1996:
“You go to see Michael Jordan play for the same reason you went to see Astaire dance, Olivier act or the sun set over Canada.
It’s art. It should be painted, not photographed.It’s not a game, it’s a recital. He’s not just a player, he’s a virtuoso.
Heifetz with a violin. Horowitz at the piano.”
Indeed, it seems reasonable to suggest that the reasons we appreciate sport at its elite level have something to do with competition, but also a great deal to do with the appreciation of an extraordinary performance.
Clearly the application of this kind of creativity is limited by the rules of the sport. Riding a motorbike would not be a “creative” solution to winning the Tour de France, and there are good reasons for proscribing this in the rules. If motorbikes were allowed, it would still be a good sport, but it would no longer be a bicycle race.
We should not think that allowing cyclists to take EPO would turn the Tour de France into some kind of “drug race”, any more than the various training methods available turn it into a “training race” or a “money race”. Athletes train in different, creative ways, but ultimately they still ride similar bikes, on the same course. The skill of negotiating the steep winding descent will always be there.
People do well at sport as a result of the genetic lottery that happened to deal them a winning hand. Genetic tests are available to identify those with the greatest potential. If you have one version of the ACE gene, you will be better at long distance events. If you have another, you will be better at short distance events. Black Africans do better at short distance events because of biologically superior muscle type and bone structure. Sport discriminates against the genetically unfit. Sport is the province of the genetic elite (or freak).
The starkest example is the Finnish skier Eero Maentyranta. In 1964, he won three gold medals. Subsequently it was found he had a genetic mutation that meant that he “naturally” had 40–50% more red blood cells than average.15 Was it fair that he had significant advantage given to him by chance?
The ability to perform well in sporting events is determined by the ability to deliver oxygen to muscles. Oxygen is carried by red blood cells. The more red blood cells, the more oxygen you can carry. This in turn controls an athlete’s performance in aerobic exercise. EPO is a natural hormone that stimulates red blood cell production, raising the packed cell volume (PCV)—the percentage of the blood comprised of red blood cells. EPO is produced in response to anaemia, haemorrhage, pregnancy, or living at altitude. Athletes began injecting recombinant human EPO in the 1970s, and it was officially banned in 1985.16
At sea level, the average person has a PCV of 0.4–0.5. It naturally varies; 5% of people have a packed cell volume above 0.5,17 and that of elite athletes is more likely to exceed 0.5, either because their high packed cell volume has led them to success in sport or because of their training.18
Raising the PCV too high can cause health problems. The risk of harm rapidly rises as PCV gets above 50%. One study showed that in men whose PCV was 0.51 or more, risk of stroke was significantly raised (relative risk = 2.5), after adjustment for other causes of stroke.19 At these levels, raised PCV combined with hypertension would cause a ninefold increase in stroke risk. In endurance sports, dehydration causes an athlete’s blood to thicken, further raising blood viscosity and pressure.20 What begins as a relatively low risk of stroke or heart attack can rise acutely during exercise.
In the early 1990s, after EPO doping gained popularity but before tests for its presence were available, several Dutch cyclists died in their sleep due to inexplicable cardiac arrest. This has been attributed to high levels of EPO doping.21 The risks from raising an athlete’s PCV too high are real and serious.
Use of EPO is endemic in cycling and many other sports. In 1998, the Festina team was expelled from the Tour de France after trainer Willy Voet was caught with 400 vials of performance enhancing drugs.22 The following year, the World Anti-Doping Agency was established as a result of the scandal. However, EPO is extremely hard to detect and its use has continued. Italy’s Olympic anti-doping director observed in 2003 that the amount of EPO sold in Italy outweighed the amount needed for sick people by a factor of six.23
In addition to trying to detect EPO directly, the International Cycling Union requires athletes to have a PCV no higher than 0.5. But 5% of people naturally have a PCV higher than 0.5. Athletes with a naturally high PCV cannot race unless doctors do a number of tests to show that their PCV is natural. Charles Wegelius was a British rider who was banned and then cleared in 2003. He had had his spleen removed in 1998 after an accident, and as the spleen removes red blood cells, its absence resulted in an increased PCV.24
There are other ways to increase the number of red blood cells that are legal. Altitude training can push the PCV to dangerous, even fatal, levels. More recently, hypoxic air machines have been used to simulate altitude training. The body responds by releasing natural EPO and growing more blood cells, so that it can absorb more oxygen with every breath. The Hypoxico promotional material quotes Tim Seaman, a US athlete, who claims that the hypoxic air tent has “given my blood the legal ‘boost’ that it needs to be competitive at the world level.”25
There is one way to boost an athlete’s number of red blood cells that is completely undetectable:26 autologous blood doping. In this process, athletes remove some blood, and reinject it after their body has made new blood to replace it. This method was popular before recombinant human EPO became available.
“By allowing everyone to take performance enhancing drugs, we level the playing field.”
There is no difference between elevating your blood count by altitude training, by using a hypoxic air machine, or by taking EPO. But the last is illegal. Some competitors have high PCVs and an advantage by luck. Some can afford hypoxic air machines. Is this fair? Nature is not fair. Ian Thorpe has enormous feet which give him an advantage that no other swimmer can get, no matter how much they exercise. Some gymnasts are more flexible, and some basketball players are seven feet tall. By allowing everyone to take performance enhancing drugs, we level the playing field. We remove the effects of genetic inequality. Far from being unfair, allowing performance enhancement promotes equality.
JUST FOR THE RICH?
Would this turn sport into a competition of expensive technology? Forget the romantic ancient Greek ideal. The Olympics is a business. In the four years before the Athens Olympics, Australia spent $547 million on sport funding,27 with $13.8 million just to send the Olympic team to Athens.28 With its highest ever funding, the Australian team brought home 17 gold medals, also its highest. On these figures, a gold medal costs about $32 million. Australia came 4th in the medal tally in Athens despite having the 52nd largest population. Neither the Australian multicultural genetic heritage nor the flat landscape and desert could have endowed Australians with any special advantage. They won because they spent more. Money buys success. They have already embraced strategies and technologies that are inaccessible to the poor.
Paradoxically, permitting drugs in sport could reduce economic discrimination. The cost of a hypoxic air machine and tent is about US$7000.29 Sending an athlete to a high altitude training location for months may be even more expensive. This arguably puts legal methods for raising an athlete’s PCV beyond the reach of poorer athletes. It is the illegal forms that level the playing field in this regard.
One popular form of recombinant human EPO is called Epogen. At the time of writing, the American chain Walgreens offers Epogen for US$86 for 6000 international units (IU). The maintenance dose of EPO is typically 20 IU per kg body weight, once a week.30 An athlete who weighs 100 kg therefore needs 2000 IU a week, or 8600 IU a month. Epogen costs the athlete about US$122 a month. Even if the Epogen treatment begins four years before an event, it is still cheaper than the hypoxic air machine. There are limits on how much haemoglobin an athlete can produce, however much EPO they inject, so there is a natural cap on the amount of money they can spend on this method.
Meanwhile, in 2000, the cost of an in competition recombinant EPO test was about US$130 per sample.31 This test is significantly more complex than a simple PCV test, which would not distinguish exogenous or endogenous EPO. If monetary inequalities are a real concern in sport, then the enormous sums required to test every athlete could instead be spent on grants to provide EPO to poorer athletes, and PCV tests to ensure that athletes have not thickened their blood to unsafe levels.
Should there be any limits to drugs in sport?
There is one limit: safety. We do not want an Olympics in which people die before, during, or after competition. What matters is health and fitness to compete. Rather than testing for drugs, we should focus more on health and fitness to compete. Forget testing for EPO, monitor the PCV. We need to set a safe level of PCV. In the cycling world, that is 0.5. Anyone with a PCV above that level, whether through the use of drugs, training, or natural mutation, should be prevented from participating on safety grounds. If someone naturally has a PCV of 0.6 and is allowed to compete, then that risk is reasonable and everyone should be allowed to increase their PCV to 0.6. What matters is what is a safe concentration of growth hormone—not whether it is natural or artificial.
We need to take safety more seriously. In the 1960s, East German athletes underwent systematic government sanctioned prescription of anabolic steroids, and were awarded millions of dollars in compensation in 2002. Some of the female athletes had been compelled to change their sex because of the large quantities of testosterone they had been given.32
We should permit drugs that are safe, and continue to ban and monitor drugs that are unsafe. There is another argument for this policy based on fairness: provided that a drug is safe, it is unfair to the honest athletes that they have to miss out on an advantage that the cheaters enjoy.
Taking EPO up to the safe level, say 0.5, is not a problem. This allows athletes to correct for natural inequality. There are of course some drugs that are harmful in themselves —for example, anabolic steroids. We should focus on detecting these because they are harmful not because they enhance performance.
Far from harming athletes, paradoxically, such a proposal may protect our athletes. There would be more rigorous and regular evaluation of an athlete’s health and fitness to perform. Moreover, the current incentive is to develop undetectable drugs, with little concern for safety. If safe performance enhancement drugs were permitted, there would be greater pressure to develop safe drugs. Drugs would tend to become safer.
This is perhaps best illustrated by the case of American sailor Kevin Hall. Hall lost his testicles to cancer, meaning that he required testosterone injections to remain healthy. As testosterone is an anabolic steroid, he had to prove to four separate governing bodies that he was not using the substance to gain an advantage.33 Any tests that we do should be sensitive to the health of the athlete; to focus on the substances themselves is dogmatic.
Not only this, but health testing can help to mitigate the dangers inherent in sport.
For many athletes, sport is not safe enough without drugs. If they suffer from asthma, high blood pressure, or cardiac arrhythmia, sport places their bodies under unique stresses, which raise the likelihood of a chronic or catastrophic harm. For example, between 1985 and 1995, at least 121 US athletes collapsed and died directly after or during a training session or competition—most often because they had hypertrophic cardiomyopathy or heart malformations.34 The relatively high incidence of sudden cardiac death in young athletes has prompted the American Heart Association to recommend that all athletes undergo cardiac screening before being allowed to train or compete.35
Sometimes, the treatments for these conditions will raise the performance of an athlete beyond that which they could attain naturally. But safety should come first. If an archer requires β blockers to treat heart disease, we should not be concerned that this will give him or her an advantage over other archers. Or if an anaemic cyclist wants to take EPO, we should be most concerned with the treatment of the anaemia.
If we are serious about safety in sport, we should also be prepared to discuss changes to the rules and equipment involved in sports which are themselves inherently dangerous. Formula One motor racing, once the most deadly of sports, has not seen a driver death in over six years, largely because of radical changes in the safety engineering of the tracks and the cars. Meanwhile, professional boxing remains inherently dangerous; David Rickman died during a bout in March 2004, even though he passed a physical examination the day before.36
Linford Christie, who served a two year drug ban from athletics competition, said that athletics “is so corrupt now I wouldn’t want my child doing it”.37 But apart from the moral harms to children in competing in a corrupt sport, should we withhold them from professional sport for medical reasons?
The case where the athletes are too young to be fully autonomous is different for two important reasons. Firstly, children are much less capable of rejecting training methods and treatments that their coach wishes to use. Secondly, we think it is worth protecting the range of future options open to a child.
There is a serious ethical problem with allowing children to make any kind of choice that substantially closes off their options for future lifestyles and career choices. If we do not consider children competent for the purposes of allowing them to make choices that cause them harm, then we should not allow them to decide to direct all of their time to professional gymnastics at age 10. The modifications such a choice can make to a child’s upbringing are as serious, and potentially as harmful, as many of the available performance enhancing drugs. Children who enter elite sport miss large parts of the education and socialisation that their peers receive, and are submitted to intense psychological pressure at an age when they are ill equipped to deal with it.
We argue that it is clear that children, who are not empowered to refuse harmful drugs, should not be given them by their coaches or parents. But the same principles that make this point obvious should also make it obvious that these children should not be involved in elite competitive sport in the first place. However, if children are allowed to train as professional athletes, then they should be allowed to take the same drugs, provided that they are no more dangerous than their training is.
Haugen’s model showed that one of the biggest problems in fighting drug use was that the size of the rewards for winning could never be overshadowed by the penalties for being caught. With this in mind, we can begin to protect children by banning them from professional sport.
CLIMATE OF CHEATING
If we compare the medical harms of the entire worldwide doping problem, they would have to be much less than the worldwide harms stemming from civilian illicit drug use. And yet, per drug user, the amount of money spent on combating drugs in sport outweighs the amount spent on combating civilian drug use by orders of magnitude.
We can fairly assume that if medical harms and adherence to law were the only reasons we felt compelled to eradicate doping, then the monetary value we placed on cleaning up sport should be the same, per drug user, as the monetary value we place on eradicating recreational drug use. And yet it is not.
Because of this, it should be obvious that it is not medical harms that we think are primarily at stake, but harm to sport as a whole, a purported violation of its spirit. It is a problem for the credibility of elite sport, if everyone is cheating.
If it is this climate of cheating that is our primary concern, then we should aim to draft sporting rules to which athletes are willing to adhere.
It is one thing to argue that banning performance enhancing drugs has not been successful, or even that it will never be successful. But it should also be noted that the prohibition of a substance that is already in demand carries its own intrinsic harms.
The Prohibition of Alcohol in America during the 1920s led to a change in drinking habits that actually increased consumption. Driven from public bars, people began to drink at home, where the alcohol was more readily available, and the incidence of deaths due to alcoholism rose or remained stable, while they dropped widely around the world in countries without prohibition.38 Furthermore, as the quality of the alcohol was unregulated, the incidence of death from poisoned alcohol rose fourfold in five years.39
Even when prohibition leads to a decrease in consumption, it often leads to the creation of a black market to supply the continuing demand, as it did in the Greenland study of alcohol rationing.40 Black markets supply a product that is by definition unregulated, meaning that the use is unregulated and the safety of the product is questionable.
The direct risks from prohibiting performance enhancing drugs in sport are similar, but probably much more pronounced. Athletes currently administer performance enhancing substances in doses that are commensurate with the amount of performance gain they wish to attain, rather than the dose that can be considered “safe”. The athletic elite have near unlimited funds and the goal of near unlimited performance, a framework that results in the use of extremely unsafe doses. If athletes are excluded when their bodies are unsafe for competition, this kind of direct consequence from prohibition would be reduced.
THE PROBLEM OF STRICT LIABILITY
Lord Coe, a dual Olympic champion, has defended the doctrine of “strict liability”, as it is currently applied to athletes who use a banned substance:41
“…The rule of strict liability—under which athletes have to be solely and legally responsible for what they consume—must remain
supreme. We cannot, without blinding reason and cause, move one millimetre from strict liability—if we do, the battle to save
sport is lost.”
The best reason for adhering to this rule is that, if coaches were made responsible for drugs that they had given to their athletes, then the coach would be banned or fined, and the athlete could still win the event. In this situation, other athletes would still be forced to take drugs in order to be competitive, even though the “cheat” had been caught.
But the doctrine of strict liability makes victims of athletes such as those of the East German swim team, who are competing in good faith but have been forced to take drugs. It also seems dogmatically punitive for athletes like British skier Alain Baxter, who accidentally inhaled a banned stimulant when he used the American version of a Vicks decongestant inhaler, without realising that it differed from the British model.42
It seems that strict liability is unfair to athletes, but its absence is equally unfair. Our proposal solves this paradox—when we exclude athletes only on the basis of whether they are healthy enough to compete, the question of responsibility and liability becomes irrelevant. Accidental or unwitting consumption of a risky drug is still risky; the issue of good faith is irrelevant.
Michael Ashenden43 proposes that we keep progressive logs of each athlete’s PCV and hormone concentrations. Significant deviations from the expected value would require follow up testing. The Italian Cycling Federation decided in 2000 that all juniors would be tested to provide a baseline PCV and given a “Hematologic Passport”.
Although this strategy is in many ways preferable to the prohibition of doping, it does nothing to correct the dangers facing an athlete who has an unsafe baseline PCV or testosterone concentration.
TEST FOR HEALTH, NOT DRUGS
The welfare of the athlete must be our primary concern. If a drug does not expose an athlete to excessive risk, we should allow it even if it enhances performance. We have two choices: to vainly try to turn the clock back, or to rethink who we are and what sport is, and to make a new 21st century Olympics. Not a super-Olympics but a more human Olympics. Our crusade against drugs in sport has failed. Rather than fearing drugs in sport, we should embrace them.
In 1998, the president of the International Olympic Committee, Juan-Antonio Samaranch, suggested that athletes be allowed to use non-harmful performance enhancing drugs.44 This view makes sense only if, by not using drugs, we are assured that athletes are not being harmed.
Performance enhancement is not against the spirit of sport; it is the spirit of sport. To choose to be better is to be human. Athletes should be the given this choice. Their welfare should be paramount. But taking drugs is not necessarily cheating. The legalisation of drugs in sport may be fairer and safer.
The legalisation of drugs in sport may be fairer and safer
An earlier, abridged version of this piece was published as “Good sport, bad sport” in